1. 2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine. (20th October 2022) Authors: Oaknin, Ana; Lorusso, Domenica; Oza, Amit; Colombo, Nicoletta; van Gorp, Toon; O'Malley, David; Banerjee, Susana; Murphy, Conleth; Harter, Philipp; Konecny, Gottfried; Kaminsky, Marie-Christine; Method, Michael; Wang, Jiuzhou; Coleman, Robert L; Birrer, Michael; Matulonis, Ursula; Moore, Kathleen Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer. (9th November 2020) Authors: O'Malley, David; Feliu, Waldo Ortuzar; Ray-Coquard, Isabelle; O'Neal, Michael; Alexandre, Jerome; Cole, Julie; Ludwig, Robert; Nallewar, Madhavi; Buell, Jennifer; Kaleta, Remigiusz; Wijatyk, Anna; Borisovskaya, Victoria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer. (9th November 2020) Authors: O'Malley, David; Feliu, Waldo Ortuzar; Ray-Coquard, Isabelle; O'Neal, Michael; Alexandre, Jerome; Cole, Julie; Ludwig, Robert; Nallewar, Madhavi; Buell, Jennifer; Kaleta, Remigiusz; Wijatyk, Anna; Borisovskaya, Victoria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 39/#452 Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study. (4th December 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan; Pikiel, Joanna; Mirza, Mansoor; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Veneris, Jennife... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. Issue 5 (May 2021) Authors: Coleman, Robert L; Lorusso, Domenica; Gennigens, Christine; González-Martín, Antonio; Randall, Leslie; Cibula, David; Lund, Bente; Woelber, Linn; Pignata, Sandro; Forget, Frederic; Redondo, Andrés; Vindeløv, Signe Diness; Chen, Menghui; Harris, Jeffrey R; Smith, Margaret; Nicacio, Leonardo Viana;... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?. (25th August 2021) Authors: Cosgrove, Casey M.; Backes, Floor J.; O'Malley, David; Bixel, Kristin L.; Suarez, Adrian A.; Fowler, Jeffrey M.; Copeland, Larry J.; Goodfellow, Paul J.; Cohn, David E. Journal: Oncologist Issue: Volume 26:Number 12(2021) Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP197/#293 Endometrial cancer recurrences in the era of COVID. (4th December 2022) Authors: Patterson, Jenna; Riedinger, Courtney; Backes, Floor; O'Malley, David; Bixel, Kristin; Copeland, Larry; Cohn, David; Goodfellow, Paul; Cosgrove, Casey Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EP233/#541 Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease following first-line chemotherapy: PRIMA/ENGOT-ov26/GOG-3012 post-hoc subgroup analysis. (4th December 2022) Authors: Kamavra, M; Gonzalez-Martin, Antonio; Pothuri, Bhavana; Vergote, Ignace; Graybill, Whitney S; Mirza, Mansoor; Mccormick, Colleen; Lorusso, D; Freyer, G; O'Malley, David; York, Whitney; Malinowska, Izabela A; Monk, Bradley Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma. (4th December 2022) Authors: Coleman, Robert L; Oza, Amit; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert; Gancedo, Margarita Amenedo; Fong, Peter; Goh, Jeffrey; O'Malley, David; Goble, Sandra; Malon... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. O011/#496 Mirvetuximab soravtansine and bevacizumab in folate receptor αlpha-positive ovarian cancer: efficacy in patients with and without prior bevacizumab. (4th December 2022) Authors: O'Malley, David; Oaknin, Ana; Matulonis, Ursula; Mantia-Smaldone, Gina; Lim, Peter; Castro, Cesar M; Provencher, Diane; Memarzadeh, Sanaz; Method, Michael; Wang, Jiuzhou; Esteves, Brooke; Moore, Kathleen; Gilbert, Lucy Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗